Search results for "clinical utility"

showing 3 items of 3 documents

Genomic Testing for Human Health and Disease Across the Life Cycle: Applications and Ethical, Legal, and Social Challenges

2019

The expanding use of genomic technologies encompasses all phases of life, from the embryo to the elderly, and even the posthumous phase. In this paper, we present the spectrum of genomic healthcare applications, and describe their scope and challenges at different stages of the life cycle. The integration of genomic technology into healthcare presents unique ethical issues that challenge traditional aspects of healthcare delivery. These challenges include the different definitions of utility as applied to genomic information; the particular characteristics of genetic data that influence how it might be protected, used and shared; and the difficulties applying existing models of informed con…

Computer scienceclinical utilityReviewDiseasegenomic testingmolecular diagnostics03 medical and health sciencesHuman health0302 clinical medicineHealthcare deliverygenetic diseaseInformed consentHealth caregenomics030212 general & internal medicineScope (project management)business.industrylcsh:Public aspects of medicine030503 health policy & servicesPublic Health Environmental and Occupational Healthhealthcarelcsh:RA1-1270Genomic technologyEngineering ethicsPublic Healthgenomic dataPersonalized medicine0305 other medical sciencebusinessFrontiers in Public Health
researchProduct

Rubinstein-Taybi syndrome (CREBBP, EP300)

2011

1.2 OMIM# of the disease180849.1.3 Name of the analyzed genes or DNA/chromosome segmentsCREBBP, EP300 (E1A binding protein p300).1.4 OMIM# of the genes600140 (CREBBP), 602700 (EP300).1.5 Mutational spectrumMainly frameshift, nonsense, splice site and missense mutations. Lessfrequently large deletions (one or more exons) and rarely balancedinversions and translocations. Mutations are heterozygous, and mosaicmutations have been described. At present, more than 100 pathogenicmutations are known for the two genes together, but mutations inEP300 are much less common (only 11 so far).

Rubinstein-Taybi SyndromeGeneticsMutationRubinstein–Taybi syndromebiologymedicine.disease_causemedicine.diseaseCREB-Binding ProteinSensitivity and SpecificityMolecular biologyFrameshift mutationExonPredictive Value of TestsMutationClinical Utility Gene CardGeneticsmedicinebiology.proteinHumansMissense mutationCREB-binding proteinEP300E1A-Associated p300 ProteinGeneGenetics (clinical)
researchProduct

Clinical utility gene card for: von Hippel-Lindau (VHL).

2013

von Hippel-Lindau Diseasemedicine.diagnostic_testGenotypeVon Hippel-Lindau Tumor Suppressor ProteinBiologyVon hippel lindaumedicine.diseasePhenotypeCyclin D1PhenotypeVon Hippel-Lindau Tumor Suppressor ProteinGenotypeClinical Utility Gene CardGeneticsmedicineCancer researchHumansCyclin D1Genetic TestingVon Hippel–Lindau diseaseGeneGenetics (clinical)Genetic testingEuropean journal of human genetics : EJHG
researchProduct